The bill aims to revise preauthorization laws by directing the Department of Public Health and Human Services to eliminate the requirement for prior authorization for certain antipsychotic drugs. Specifically, it states that the department may not require prior authorization under the Medicaid program for any antipsychotic drug that has been approved by the federal drug administration and is recognized in the latest edition of the Diagnostic and Statistical Manual of Mental Disorders by the American Psychiatric Association for treating specified conditions.

Additionally, the bill includes provisions for its effective date and applicability, stating that it will take effect 30 days after being passed and approved, and will apply to claims submitted for payment for services provided on or after the effective date.